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Measuring quality of life in ALS/MND: Validation of the WHOQOL-BREF 
 
Abstract 
Objectives: The World Health Organization Quality of Life-BREF Scale (WHOQOL-
BREF) is a generic QOL measure with four domains covering Physical, 
Psychological, Social and Environment. Providing the opportunity to contrast QoL 
with other conditions, or with population norms, the current study had three aims: 1) 
can the established domains of the WHOQOL-BREF be validated within a large 
ALS/MND population; 2) can a total score be validated and 3) can they provide 
interval level measurement? 
Methods: Data were obtained from the Trajectories of Outcomes in Neurological 
Conditions study.  Internal construct validity was determined by fit of the data to the 
Rasch measurement model.  
Results: 636 participants with ALS/MND were included. All domains, except the 
Social domain, showed satisfactory fit to the Rasch model. All were unidimensional, 
and showed no Differential Item Functioning by age, gender, or onset type. Finally, a 
total score was validated from a bi-factor perspective.  
Conclusions: The WHOQOL-BREF is valid for use in populations with ALS/MND 
and can be analysed to yield interval level measurement: It offers a range of 
domains that reflect QOL, which can be used for parametric analysis and for 
comparison with other conditions or general populations, two advantages for its 
inclusion as a trial outcome measure and for observational studies.   
  
  







Provision of care for people with Motor Neuron Disease (MND), also known as 
Amyotrophic Lateral Sclerosis (ALS), is enhanced by a thorough understanding of 
how symptoms and functioning relate to quality of life (QOL). This relationship is 
expressed in the Wilson and Cleary model, which recognised that symptoms and 
functioning (health status) are separate to QOL (1). Many widely used HRQOL 
measures include items covering symptoms and functioning, potentially confounding 
analysis of how symptoms and functioning affect QOL (2). Furthermore, their 
weighting toward physical functioning can lead to the interpretation that QOL 
declines as the disease progresses (for review, see Simmons 2015) (3). However, 
studies using measures adopting a broader construct of QOL demonstrate that QOL 
may be preserved while physical function declines (4, 5). 
 
The World Health Organization (WHO) designed broader QOL measures including 
not only the persons' physical health and psychological state, but also their level of 
independence, social relationships and their relationship to salient features of their 
environment (6). The WHO Quality of Life BREF Scale (WHOQOL-BREF) is a 
shortened version of the 100-item WHOQOL, with 26 items, 24 of which are scored. 
Its psychometric properties were analysed using data from almost 12,000 adults, 
with a variety of health states, recruited from hospital, rehabilitation and primary care 
settings (7).  A multi-rater mapping process concluded that the WHOQOL-BREF has 
the fewest items concerning function out of five widely used generic measures of 
HRQOL, at 27% of items in contrast to the 83% of items concerning function for the 
Short Form Health Survey (SF-36) or EQ‐5D, and even more for the Health Utility 
Index or SF-12 (2, 8).   
 
The aims of the current study were to: a) establish if the original domains of the 
WHOQOL-BREF can be obtained and validated within a large ALS/MND population; 
b) to examine if a total score can be validated and c) describe differences in domain 
scores, using an interval-scaled metric, according to different demographic and 




Data were obtained from an ongoing longitudinal study concerning the trajectories of 
outcome for those with ALS/MND, the Trajectories of Outcomes in Neurological 
Conditions (TONiC) study (9).  Participants with ALS/MND, diagnosed according to 
El Escorial World Federation of Neurology criteria (10), were recruited from 
multidisciplinary specialist clinics across the United Kingdom.  Cases with a family 
history of ALS/MND were eligible as were patients with only lower motor neuron 
(LMN) signs in 2 or more regions, or with progressive primary lateral sclerosis 
without spinal LMN signs, provided a consultant neurologist specialising in ALS/MND 
had confirmed the diagnosis.  
 
Participants were excluded if they were unable to give informed consent, such as 
from cognitive deficits related to frontotemporal dementia, or if they were unable to 
complete self-report questionnaires even with help from a scribe. They completed a 
questionnaire which contained a range of Patient Reported Outcome Measures 
(PROMs) including the WHOQOL-BREF, Amyotrophic Lateral Rating Scale-Revised 
(ALSFRS-R), as well as disease duration and site of onset provided by their clinician.  
All participants received written information and informed consent was obtained prior 
to enrolment into the study.  Ethical approval was granted from the relevant local 
research committees (reference 11/NW/0743). 
 
Scales 
The WHOQOL-BREF begins with two single summary items on quality of life and 
health which are not scored with the rest of the item set, and then continues with 24 
items covering four domains: (a) Physical health and well-being (seven items); (b) 
Psychological health and well-being (six items); (c) Social relations (three items); and 
(d) Environment (eight items). Each item has a five-point rating scale from 0-4 (or 
sometimes scored 1-5); the higher the item score, the better one’s ‘quality of life’ on 
the domain covered by the item. While it might be thought that items belonging to the 
Environment domain would be least likely to represent quality of life, they are worded 
in such a way that this is exactly the case, for example, “How satisfied are you with 
the conditions of your living place?”  Even for functioning and the classical Activities 
of Daily Living, rather than the level of difficulty with activities, the question is “How 
satisfied are you with your ability to perform your daily living activities”. Thus while 
the Physical, Psychological, Social and Environmental domains look, at first sight, to 
be similar to classical ‘functioning’ scales as found in the Health Related Quality of 
Life (HRQoL) literature, their perspective is more one of appraisal of aspects related 
to these domains, rather than the actual ‘doing’ of tasks related to those domains. It 
is this that provides a unique perspective upon Quality of Life. Further information 
including a copy of the WHOQOL-BREF is available from the WHO website at 
https://www.who.int/mental_health/media/en/76.pdf.  
 
The Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) 
was developed to monitor the progression of disability in patients with ALS (11). The 
12 items are scored 0-4 with a total score of 48, where lower scores indicate greater 
disability. 
 
Four further scales were included to contribute towards an understanding of the 
external construct validity of the WHOQOL-BREF: 
 
1. Modified Hospital Anxiety and Depression scale (mHADS), with each domain 
having six items, and associated clinical cuts to identify ‘possible’ and ‘probable’ 
anxiety or depression (12)  
2. World Health Organization’s Disability Assessment Schedule–2.0 (WHODAS-
2.0), which summates 32 items covering communicating, getting around, self-
care, getting along with others, household activities, and participation in society, 
analysed without the 4 work-related items (13), 
3. EQ-5D-5L utility score, measured with a visual analog scale (VAS), which records 
the respondent's self-rated health status on a graduated (0–100) scale, with 
higher scores for better HRQOL (14), 
4. Numeric Rating Scale (NRS) of perceived overall Quality of Life, where a high 
score is better. 
 
Statistical analysis 
Internal construct validity of the various domains of the WHOQOL-BREF was 
determined by fit of the data to the Rasch measurement model, full details of which 
can be found elsewhere (15, 16). Briefly, data must satisfy the requirements of the 
model, including local item independence, unidimensionality, and stochastic ordering 
of items (17). Acceptable values of these requirements are shown at the foot of the 
fit table.  Residual item correlations of 0.2 above the average residual correlations 
were indicative of local item dependency (18). These dependencies can arise from 
redundancy, that is, items are close replicates of one another, or from 
multidimensionality. Where the assumption of local item independence is breached, 
‘testets’ or ‘super items’ are formed by adding the dependent items together (19). 
Here we use the term testlet as a group of items which can be identified a priori, for 
example where there are subscale structures. Where empirical findings show local 
item dependency without a priori input, we refer to any such subsequent grouping of 
items as ‘super items’. A number of strategies are available for this purpose, 
depending upon the pattern and extent of local dependency. For example, in the 
absence of any predefined underlying structure, each pair of locally dependent items 
can be grouped together into a super item. Also, in the RUMM2030 Rasch software, 
two testlets/super items absorbing all items can provide a latent estimate based 
upon a bi-factor equivalent solution where a (stronger) conditional test of fit becomes 
available (20). The explained common variance (ECV) is reported where a value of 1 
indicates that all non-error variance is contained within the latent estimate. An ECV 
value > 0.9 is considered sufficient to indicate that the first common (in this case 
Rasch) factor is essentially unidimensional (21). Values marginally above 1 can be 
obtained, indicating that some local dependency nevertheless remains across the 
two testlets/super items.  Finally, tests of invariance (Differential Item Functioning 
(DIF)) of the various domains are made for age, gender and onset type (constrained 
to limb and bulbar due to small numbers in other groups) (22).  
 
In order to assess external construct validity, Spearman’s correlations were analysed 
between the WHOQOL-BREF total and domains with four other scales: mHADS, 
WHODAS-2.0, EQ5D-5L utility score and NRS of QOL.  
 
Absolute reliability was determined through the Standard Error of Measurement 
(SEM) and the Smallest Detectable Difference (SDD). SEM is calculated as SEM = 
SD all testing scores× √ (1－reliability). SDD represents the minimal difference that a 
patient or group must show on the scale to ensure that the observed difference is 
real and not just measurement error, and was calculated as 1.96 × √2 × SEM where 
1.96 derives from the 95% CI (23).  
 
Results 
636 patients with ALS/MND returned a baseline questionnaire by early 2018. Mean 
age was 65.1 years (SD 10.7) and 61.3% were male (Table 1). Over three quarters 
(78.6%) were married, and 40% considered themselves to be religious or spiritual. 
Just over three fifths (61%) were able to complete the questionnaire independently; 
85% completed all the items of the WHOQOL-BREF, and 95% all but one item.    
Median ALSFRS-R score was 33.  
 
Initial fit of the data to the Rasch model found that local item dependency was 
present throughout the scale; within the existing Physical and Psychological 
domains, and in a total 24-item set. Only the Environmental domain was free of local 
item dependency; the Social scale had too few items to detect local dependency. For 
example, in the 24-item set, nine pairs of items showed residual correlations above 
0.2, mostly clustering within established domains. Likewise, independently, the 
Physical and Psychological domains also showed several pairs of locally dependent 
items. Consequently, items were grouped to remove the effect of the dependency.   
 
Given this, the fit of the various domains is shown in Table 2. All but the Social 
domain, showed satisfactory fit to the model. All were unidimensional, and there was 
no DIF by age, gender, or onset type (bulbar versus limb). Indeed, in the basic 24-
item analysis (not shown) only the item ‘Are you able to accept your bodily 
appearance’ showed DIF by age.  
 
Finally, using the original four domains as testlets, a total score was validated, albeit 
with 8% of the variance discarded to obtain the bi-factor unidimensional latent 
estimate. The person item distribution of the total score is shown in Figure 1. The 
scale is well targeted, and its range adequately encompasses those of the sample.    
 
Raw score to interval scale transformations for all solutions are shown in Table 3.  
Providing the respondent has answered all the items within the domain(s) of interest, 
the raw score can be summated by adding the scores of 0-4 for each item. (If the 
data are scored as 1-5, then adjust the scores on the transformation table, for 
example, with the Physical scale of 7 items, add 7 to the raw score and the 
transformed score). Thus, if interval level measures of Total QOL, or QOL domains 
concerning Physical, Psychological and Environment are required, the raw score can 
be converted to an interval scale metric. The metrics have the same operational 
range as the raw score. 
 
The values of the domains with respect to various demographic, clinical and other 
PROM-related aspects are shown in Table 4.  All domains showed a significant 
difference and strong gradient across ALSFRS-R levels, with post-hoc analysis 
showing that all pairwise comparisons were significant with the exception of the 
comparison between the ALSFRS-R total scores 0-12 and 13-24, possibly as a 
result of the lowest scoring group containing only 8 cases. The Physical domain 
differed across onset types of limb and bulbar, while most domains did not 
significantly differ by gender or age.     
 
It is instructive to look at the precision of the domains as expressed through their 
SEM, their SDD, and the percent of the operational range of the scale implied by the 
SDD (SDD%) (Table 5). The WHOQOL-BREF Total score is the most efficient in that 
just 8.3% of its operational range needs to be traversed to be above the error. As a 
contrast, the ALSFRS-R Bulbar domain requires a shift of 33.5% to be sure that any 
difference is meaningful and not just influenced by error.     
 
Finally, Table 6 presents the non-parametric (Spearmans) correlations of the 
WHOQOL-BREF domains (excluding Social) against various other measures 
included in the study, in order to evaluate external construct validity. As expected, 
correlations were mostly of moderate strength, with the WHOQOL-BREF 
Psychological domain showing the strongest correlation with the mHADS Depression 
scale, and the Physical domain showing a strong correlation with the WHODAS-2.0. 
It should be noted that the Total score from the WHOQOL-BREF explains 42.2% of 
the variance of the NRS QoL Summary item.    
 
Discussion 
The WHOQOL-BREF has been shown to display internal construct validity for 
ALS/MND, with the exception of the Social scale which cannot be used as a 
separate domain, although its items are included in the Total score. Excluding the 
Social scale, all remaining domains demonstrated invariance of age, gender and 
onset type and showed acceptable levels of unidimensionality and fit to the Rasch 
model. Both the Total raw score and the Psychological domain raw score were found 
to be marginally multidimensional, requiring a bi-factor equivalent solution, and 
therefore it is necessary to use their respective interval scaled transformed scores, 
which are based upon a slightly reduced variance.  These findings are mostly 
consistent with those reported by Noerholm et al., who found that in a general 
population study the physical, psychological and environmental domains fit a two-
parameter item response theory model, but not the social domain (24). A bi-factor 
solution for the Total score of the WHOQOL-BREF has also been proposed 
elsewhere (25).  
 
Most recently, an ALS/MND-specific QoL scale has been developed with scope for a 
different QoL end-point where comparability with other conditions or populations is 
not required (26).  In contrast, the WHOQOL-BREF offers a set of domains which is 
built upon the appraisal of different facets of QOL and provides a distinctive generic 
measure of QoL.   
 
There are several strengths emerging from the findings of the study. First, the 
WHOQOL-BREF is a simple, self-report measure; in this study 85% of people 
completed all 26 items at home without any assistance from a researcher. In 
addition, it appears to have good acceptability among respondents, a further 10% of 
people completed 25 out of 26 items. The very low amount of missing data suggests 
that the items are relevant for people with ALS. This is in keeping with findings in a 
sample of 4669 people including 27 diagnoses or healthy controls, where just 41 
subjects had missing data such that the  WHOQOL-BREF could not be scored (27). 
Secondly, interval scale latent estimates derived from fit of data to the Rasch model 
provide the required data quality for inclusion in parametric analysis, including path 
analyses and multi-level modelling. Thirdly, generic scales such as the WHOQOL-
BREF, offer the advantage of enabling comparisons between conditions and with 
general populations. For example less than 1% of Australian adults had WHOQOL-
BREF scores comparable to ALS/MND patients with total ALSFRS-R<13/48 (28). 
Again, it must be remembered that the WHOQOL-BREF is not about the actual level 
of functioning, but rather an appraisal of, for example, whether life is thought to be 
meaningful, whether or not the person is able to accept their bodily appearance, how 
satisfied they are with their personal relationships, and how safe they feel in their 
daily life. It is within this perspective that contrasts should be made.     
   
There are further limitations and strengths to the study. The use of the ordinal 
ALSFRS-R total score has been subjected to some criticism of late, claiming that 
rather it should be scored as three or four separate domains (29-31). Recently, a 
possible bi-factor equivalent solution to a total score for the ALSFRS-R has been put 
forward (32). In the current study the total ordinal score was grouped into quartiles of 
the operational range of the scale to allow for examination of the gradients of the 
WHOQOL-BREF domains over these quartiles, based upon a score familiar to most 
readers. The strengths of the current study include its sample size and wide range of 
functioning of those with ALS/MND, together with the application of the Rasch 
measurement model to ascertain internal construct validity.  
 
In summary, the WHOQOL-BREF is valid for use in populations with ALS/MND and, 
using the transformation table, can be analysed as interval level data across several 
domains, providing the patient has responded to all the items within the domain(s) of 
interest. It can provide a Total score, and independent domains of Physical, 
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Table 1: Clinical and demographic characteristics of the ALS patients (n =636). 
Characteristics  ALS patients 
Gender: Males (%) (61.3) 
Mean age: years (SD) 65.1 (10.7) 
Married (%): 78.6 
Considered religious or spiritual (%) 40.1 
Independent completion of Questionnaire (%) 61.0 
Site of ALS onset (%)  
  Limb 428 (67.3) 
  Bulbar 174 (27.4%) 
  Respiratory 11 (1.7%) 
  Unknown 23 (3.6%) 
Median disease duration from diagnosis: months (IQR; range) 11.2 (4.6-29.9; 0.4-295.9) 
Median ALS-FRS score (IQR: range) 33(27-38: 1-48) 
Working activity (%)  
   Employed  12.9 
   Unemployed 2.4 
   Retired 56.1 
   Unable to work because of illness or disability 22.8 
   Other 5.8 
SD=standard deviation; IQR=Inter Quartile Range; ALSFRS-R=ALS Functional Rating Scale-Revised 
Table 2: Fit of WHOQOL-BREF Domains to Rasch model. 




Super Item/Testlet Analysis 
  Item Person Value and 
(df) 










of Fit  
P value 
1 Physical –  
2 super items 
0.54 0.87 11.94 
(18) 
 
0.850 0.82 0.82 3.7 1.00 1.00 0.030 
2 Psychological –  
2 super items 
0.49 098 11.79 
(18) 
 
0.858 0.73 0.77 3.7 0.84 0.93 0.107 
3 Social –  
3 items 
1.46 0.83 55.34 
(20) 
 
<0.001 0.57 0.57 1.9 - - - 
4 Environmental -    
8 items 
1.37 1.06 100.0  
(72) 
0.016 0.77 0.78 5.6 
(3.8) 
 
- - - 
5 Total score as 4 
domain-based 
testlets 
2.02 1.11 19.52 
(36) 
0.988 0.85 0.81 4.3 0.827 0.921 - 
 Ideal Values <1.4* <1.4  >0.05 >0.7 >0.7 <5.0 (LCI) >0.8 >0.9 >0.01 
*Where testlets/super items are of the same size, else can be inflated; SD= Standard Deviation; PSI=Person Separation Index; df=Degrees of Freedom ; 
 LCI= Lower Confidence Interval





Physical Psychological Environmental 
0 0.0 0.0 0.0 0.0 
1 8.8 2.2 2.2 2.8 
2 14.2 3.7 3.7 4.7 
3 17.5 4.8 4.8 6.0 
4 19.8 5.6 5.6 6.9 
5 21.6 6.3 6.4 7.7 
6 23.0 7.0 7.1 8.4 
7 24.2 7.5 7.7 9.0 
8 25.2 8.1 8.3 9.5 
9 26.0 8.6 8.9 10.0 
10 26.8 9.1 9.5 10.5 
11 27.5 9.6 10.1 11.0 
12 28.1 10.0 10.7 11.4 
13 28.6 10.5 11.3 11.9 
14 29.1 11.1 12.0 12.3 
15 29.6 11.6 12.7 12.8 
16 30.0 12.2 13.4 13.2 
17 30.4 12.8 14.2 13.7 
18 30.8 13.5 15.1 14.2 
19 31.2 14.3 16.1 14.8 
20 31.5 15.1 17.1 15.4 
21 31.9 16.0 18.3 16.1 
22 32.2 17.0 19.7 16.8 
23 32.5 18.1 21.5 17.6 
24 32.9 19.4 24.0 18.4 
25 33.2 20.9  19.3 
26 33.5 22.6  20.4 
27 33.8 24.9  21.5 
28 34.1 28.0  22.8 
29 34.4   24.3 
30 34.8   26.1 
31 35.1   28.6 
32 35.4   32.0 
33 35.7    
34 36.0    
35 36.4    
36 36.7    
37 37.0    
38 37.3    
39 37.7    
40 38.0    
41 38.4    
42 38.7    
43 39.1    
44 39.4    
45 39.8    
46 40.1    
47 40.5    
48 40.9    
49 41.2    
50 41.6    
51 42.0    
52 42.4    
53 42.8    
54 43.2    
55 43.6    
56 44.1    
57 44.5    
58 44.9    
59 45.4    
60 45.9    
61 46.4    
62 46.8    
63 47.4    
64 47.9    
65 48.4    
66 48.9    
67 49.5    
68 50.1    
69 50.7    
70 51.3    
71 51.9    
72 52.5    
73 53.2    
74 53.8    
75 54.5    
76 55.2    
77 56.0    
78 56.7    
79 57.5    
80 58.3    
81 59.1    
82 60.0    
83 60.9    
84 61.8    
85 62.8    
86 63.9    
87 65.1    
88 66.4    
89 67.8    
90 69.4    
91 71.2    
92 73.5    
93 76.3    
94 80.2    
95 86.3    
96 96.0    
 
  
Table 4. Domain Scores (on interval-scaled metric) across various demographic, 





Physical Psychological Environmental Total 
Operational 
Range 
0-28 0-24 0-32 0-96 
Gender     













Age     



















































































* Indicates satistical difference at 0.05 (posthoc tests where apropriate) 




Table 5. Precision of the WHOQOL-BREF domains and, for comparison, 
ALSFRS-R domains. All domains are on an interval scaled metric. 
 




     
Physical 14.579 3.775 2.020 5.615 20.055 
Psychological 13.602 3.265 1.531 4.245 17.687 
Environmental 19.821 4.137 1.940 5.379 16.808 
Total 48.110 7.408 2.869 7.953 8.284 
 
ALSFRS-R      
Bulbar 8.218 3.325 1.449 4.017 33.478 
Limb 13.073 5.266 2.106 5.839 24.328 
Respiratory 10.341 1.922 0.838 2.322 19.352 
 
SD=Standard Deviation; SEM= Standard Error of Measurement; SDD = Smallest 

















     
Physical -0.6706 0.7283 -0.3555 -0.5328 0.5567 
Psychological -0.4914 0.4791 -0.6119 -0.7329 0.6015 
Environmental -0.5107 0.5139 -0.3725 -0.4935 0.5408 
Total -0.6489 0.6651 -0.5000 -0.6787 0.6493 
 
 
 
